Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for DAWN

Stock NameDay One Biopharmaceuticals Inc
TickerDAWN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS23954D1090

Show aggregate DAWN holdings

News associated with DAWN

Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month Low Following Analyst Downgrade
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday after Needham & Company LLC lowered their price target on the stock from $18.00 to $16.00. Needham & Company LLC currently has a buy rating on the stock. Day One Biopharmaceuticals traded as low […] - 2025-08-07 02:46:44
Allianz Asset Management GmbH Buys Shares of 25,000 Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Allianz Asset Management GmbH bought a new stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm bought 25,000 shares of the company’s stock, valued at approximately $198,000. A number of other hedge funds have also made changes to their positions in DAWN. Wealth Enhancement […] - 2025-08-05 04:26:54
Arizona State Retirement System Reduces Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Arizona State Retirement System lessened its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 8.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,902 shares of the company’s stock after selling 1,471 shares during the quarter. Arizona State Retirement […] - 2025-07-24 04:38:49
Alps Advisors Inc. Lowers Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Alps Advisors Inc. lowered its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 10.1% during the first quarter, HoldingsChannel.com reports. The firm owned 73,343 shares of the company’s stock after selling 8,206 shares during the period. Alps Advisors Inc.’s holdings in Day One Biopharmaceuticals were worth $582,000 at the end […] - 2025-07-15 06:25:18
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $29.00 Average Price Target from Brokerages
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given a consensus rating of “Buy” by the seven analysts that are covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […] - 2025-07-14 02:56:48
Analysts Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Price Target at $30.57
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given a consensus recommendation of “Buy” by the eight analysts that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 […] - 2025-06-19 02:46:56
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 15.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 75,579 shares of the company’s stock after buying […] - 2025-06-11 05:14:48
Two Sigma Investments LP Lowers Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Two Sigma Investments LP lessened its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 33.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 271,776 shares of the company’s stock after selling 135,725 shares during the quarter. Two Sigma […] - 2025-05-30 04:51:01
Deutsche Bank AG Buys 35,460 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Deutsche Bank AG raised its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 358,920 shares of the company’s stock after buying an additional 35,460 shares during the […] - 2025-05-20 05:12:56
Mariner LLC Sells 10,376 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Mariner LLC lessened its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 47.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 11,669 shares of the company’s stock after selling 10,376 shares during the period. Mariner LLC’s holdings in Day One Biopharmaceuticals were worth $148,000 as of its most recent filing with […] - 2025-05-08 04:40:46
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up Following Earnings Beat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $6.99, but opened at $7.52. Day One Biopharmaceuticals shares last traded at $6.64, with a volume of 935,489 shares trading hands. The company reported ($0.35) earnings […] - 2025-05-08 03:12:49
Hsbc Holdings PLC Makes New Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Hsbc Holdings PLC acquired a new position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 38,583 shares of the company’s stock, valued at approximately $481,000. Several other hedge funds also […] - 2025-05-07 04:56:57
Wells Fargo & Company MN Sells 4,744 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Wells Fargo & Company MN cut its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 8.4% during the 4th quarter, Holdings Channel reports. The firm owned 51,735 shares of the company’s stock after selling 4,744 shares during the period. Wells Fargo & Company MN’s holdings in Day One Biopharmaceuticals were […] - 2025-05-02 04:24:48
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $32.29 Average Target Price from Analysts
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-04-30 02:34:47
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Acquired by Fmr LLC
Fmr LLC increased its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 73.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,887,467 shares of the company’s stock after purchasing an additional 5,475,087 shares […] - 2025-04-14 05:15:07
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Corebridge Financial Inc.
Corebridge Financial Inc. reduced its stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,805 shares of the company’s stock after selling 1,948 shares during the quarter. Corebridge Financial Inc.’s holdings in Day […] - 2025-04-11 05:40:56
Wellington Management Group LLP Grows Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Wellington Management Group LLP raised its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 731,303 shares of the company’s stock after purchasing an additional 9,722 shares during the quarter. Wellington Management […] - 2025-04-10 06:06:51
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $27.00 by Analysts at The Goldman Sachs Group
Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price objective trimmed by The Goldman Sachs Group from $39.00 to $27.00 in a research note published on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also issued reports on DAWN. JPMorgan Chase & Co. dropped their […] - 2025-03-26 04:38:43
Charles Schwab Investment Management Inc. Raises Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Charles Schwab Investment Management Inc. boosted its holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 535,501 shares of the company’s stock after buying an additional 28,053 shares during the period. Charles Schwab Investment Management Inc.’s […] - 2025-03-25 05:13:03
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Lowered to $34.00 at JPMorgan Chase & Co.
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) had its target price dropped by JPMorgan Chase & Co. from $39.00 to $34.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 273.63% from the company’s current […] - 2025-03-07 04:50:44
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year Low Following Weak Earnings
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) hit a new 52-week low on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $10.06 and last traded at $10.54, with a volume of 436845 shares. The stock had previously closed at $11.82. The company reported ($0.69) earnings […] - 2025-02-27 07:08:59
Day One Biopharmaceuticals (NASDAQ:DAWN) Given New $43.00 Price Target at The Goldman Sachs Group
Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price objective decreased by The Goldman Sachs Group from $48.00 to $43.00 in a research note released on Monday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. Several other analysts have also issued reports on DAWN. Needham & Company LLC […] - 2025-02-11 06:28:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) DAWN holdings

DateNumber of DAWN Shares HeldBase Market Value of DAWN SharesLocal Market Value of DAWN SharesChange in DAWN Shares HeldChange in DAWN Base ValueCurrent Price per DAWN Share HeldPrevious Price per DAWN Share Held
2025-11-11 (Tuesday)65,293USD 676,435USD 676,435
2025-11-10 (Monday)65,293DAWN holding increased by 168USD 663,377DAWN holding increased by 29711USD 663,377168USD 29,711 USD 10.16 USD 9.73
2025-11-07 (Friday)65,125USD 633,666DAWN holding increased by 48192USD 633,6660USD 48,192 USD 9.73 USD 8.99
2025-11-06 (Thursday)65,125DAWN holding increased by 168USD 585,474DAWN holding decreased by -8233USD 585,474168USD -8,233 USD 8.99 USD 9.14
2025-11-05 (Wednesday)64,957USD 593,707DAWN holding increased by 119521USD 593,7070USD 119,521 USD 9.14 USD 7.3
2025-11-04 (Tuesday)64,957DAWN holding increased by 170USD 474,186DAWN holding increased by 593USD 474,186170USD 593 USD 7.3 USD 7.31
2025-11-03 (Monday)64,787USD 473,593DAWN holding decreased by -8422USD 473,5930USD -8,422 USD 7.31 USD 7.44
2025-10-31 (Friday)64,787USD 482,015DAWN holding increased by 25915USD 482,0150USD 25,915 USD 7.44 USD 7.03999
2025-10-30 (Thursday)64,787DAWN holding increased by 850USD 456,100DAWN holding increased by 5984USD 456,100850USD 5,984 USD 7.03999 USD 7.03999
2025-10-29 (Wednesday)63,937DAWN holding increased by 340USD 450,116DAWN holding decreased by -16050USD 450,116340USD -16,050 USD 7.03999 USD 7.33
2025-10-28 (Tuesday)63,597USD 466,166DAWN holding decreased by -10812USD 466,1660USD -10,812 USD 7.33 USD 7.50001
2025-10-27 (Monday)63,597USD 476,978DAWN holding increased by 636USD 476,9780USD 636 USD 7.50001 USD 7.49001
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DAWN by Blackrock for IE00BYXG2H39

Show aggregate share trades of DAWN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY16810.5459.660 9.748USD 1,638 9.09
2025-11-06BUY1689.7408.967 9.045USD 1,520 9.09
2025-11-04BUY1707.4907.108 7.146USD 1,215 9.10
2025-10-30BUY8507.2606.900 6.936USD 5,896 9.13
2025-10-29BUY3407.0407.350 7.319USD 2,488 9.14
2025-10-22SELL-6767.2607.560 7.530USD -5,090 9.18 Profit of 1,118 on sale
2025-10-20BUY3387.4107.515 7.504USD 2,537 9.20
2025-10-17BUY8437.2007.490 7.461USD 6,290 9.21
2025-10-15BUY1,3367.7807.785 7.784USD 10,400 9.22
2025-10-03BUY1,1907.9508.280 8.247USD 9,814 9.24
2025-10-02BUY1707.4307.475 7.470USD 1,270 9.25
2025-09-30BUY3407.0507.110 7.104USD 2,415 9.28
2025-09-26BUY3406.7706.857 6.848USD 2,328 9.30
2025-09-25BUY3406.6806.875 6.855USD 2,331 9.32
2025-09-24SELL-4,1916.8707.080 7.059USD -29,584 9.33 Profit of 9,534 on sale
2025-09-18BUY1847.2107.210 7.210USD 1,327 9.35
2025-09-17BUY5526.9907.270 7.242USD 3,998 9.36
2025-08-20SELL-7286.8106.870 6.864USD -4,997 9.41 Profit of 1,857 on sale
2025-07-30BUY7206.8707.175 7.145USD 5,144 9.52
2025-07-17SELL-3626.5006.710 6.689USD -2,421 9.69 Profit of 1,085 on sale
2025-07-16BUY3,9986.6206.730 6.719USD 26,863 9.71
2025-07-11SELL-1,3606.7907.130 7.096USD -9,651 9.77 Profit of 3,631 on sale
2025-07-07BUY5106.6306.810 6.792USD 3,464 9.85
2025-07-02BUY9,3506.7306.949 6.927USD 64,768 9.89
2025-06-11BUY3446.7507.075 7.042USD 2,423 10.09
2025-06-10BUY3426.9807.400 7.358USD 2,516 10.12
2025-06-04SELL-1726.9307.100 7.083USD -1,218 10.21 Profit of 538 on sale
2025-04-23BUY1707.4407.740 7.710USD 1,311 11.25
2025-04-10SELL-1,3606.7607.192 7.149USD -9,722 11.67 Profit of 6,154 on sale
2025-04-08SELL-1706.7107.290 7.232USD -1,229 11.78 Profit of 773 on sale
2025-04-07SELL-1707.0207.360 7.326USD -1,245 11.84 Profit of 767 on sale
2025-04-04SELL-8557.2207.700 7.652USD -6,542 11.89 Profit of 3,624 on sale
2025-04-01BUY7007.6107.930 7.898USD 5,529 11.99
2025-03-31SELL-5137.9307.960 7.957USD -4,082 12.04 Profit of 2,094 on sale
2025-03-21BUY2,9728.2308.300 8.293USD 24,647 12.34
2025-03-14SELL-2,5928.1208.890 8.813USD -22,843 12.63 Profit of 9,884 on sale
2025-03-07SELL-3248.6709.070 9.030USD -2,926 12.93 Profit of 1,265 on sale
2025-03-04SELL-1628.6008.620 8.618USD -1,396 13.11 Profit of 728 on sale
2025-02-25BUY32211.82012.380 12.324USD 3,968 13.41
2025-02-19SELL-16011.78012.050 12.023USD -1,924 13.50 Profit of 237 on sale
2025-02-13BUY48012.21012.260 12.255USD 5,882 13.61
2025-02-12BUY16012.13012.210 12.202USD 1,952 13.64
2025-02-11BUY64011.92011.940 11.938USD 7,640 13.68
2024-12-30SELL-5,04512.58012.850 12.823USD -64,692 14.22 Profit of 7,054 on sale
2024-11-18SELL-2,58013.01013.760 13.685USD -35,307 14.91 Profit of 3,172 on sale
2024-11-08SELL-17216.39016.760 16.723USD -2,876 14.76 Loss of -338 on sale
2024-10-21SELL-17314.93014.980 14.975USD -2,591 0.00 Loss of -2,591 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DAWN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19101,088200226,93644.5%
2025-09-18103,5560310,49633.4%
2025-09-17103,0720365,04428.2%
2025-09-1679,1620291,00127.2%
2025-09-1569,3160266,55426.0%
2025-09-1286,7160211,87140.9%
2025-09-11128,9320293,67643.9%
2025-09-1079,3140382,08720.8%
2025-09-0955,4090163,76433.8%
2025-09-0890,6490294,16730.8%
2025-09-05105,3071,514322,53132.7%
2025-09-0497,40930,755230,33442.3%
2025-09-03149,4590598,85925.0%
2025-09-02131,0410357,91136.6%
2025-08-29103,0060253,07940.7%
2025-08-28142,8080342,96441.6%
2025-08-27279,7330495,58156.4%
2025-08-26244,3710437,85255.8%
2025-08-25164,7430326,39150.5%
2025-08-22185,892574527,33935.3%
2025-08-21133,0040203,71765.3%
2025-08-20160,0890295,17254.2%
2025-08-19295,0701,302645,89345.7%
2025-08-18173,7266669,91225.9%
2025-08-15246,98116565,73843.7%
2025-08-14158,7530313,52150.6%
2025-08-13261,892310805,12032.5%
2025-08-121,015,4022,8001,643,56961.8%
2025-08-11162,783117830,07919.6%
2025-08-08365,15897619,82258.9%
2025-08-07745,06610,4881,183,69262.9%
2025-08-062,444,048246,0934,453,51554.9%
2025-08-05812,7421,3862,254,65936.0%
2025-08-04231,56701,401,58116.5%
2025-08-01226,7220332,72868.1%
2025-07-31325,10772411,82278.9%
2025-07-30190,5930263,03072.5%
2025-07-29244,7096,529435,05556.2%
2025-07-28378,4340572,95766.0%
2025-07-25327,639298629,60252.0%
2025-07-24297,0430756,30239.3%
2025-07-23260,5480754,37334.5%
2025-07-22112,746374273,43241.2%
2025-07-21206,339971410,51650.3%
2025-07-18339,6445,155636,36153.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.